11.5BINR
Type
Common Stock
Exchange
BSE
Currency Code
INR
Currency Name
Indian Rupee
Country Name
India
Country ISO
IN
ISIN
INE010B01027
CUSIP
-
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
March
IPO date
-
Updated At
-
PE Ratio
21.74
PEG Ratio
1.10
Book Value
251.49
Dividend Share
1
Dividend Yield
0.09%
Earnings Share
50.09
Wall Street Target Price
1,066.50
EPS Estimate Current Year
45.16
EPS Estimate Next Year
41.81
EPS Estimate Current Quarter
9.2973
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
271,483,994,112
Gross Profit TTM
198,558,007,296
EBITDA
72,576,000,000
Profit Margin
18.57%
Return On Assets TTM
8.07%
Return On Equity TTM
18.32%
Revenue Per Share TTM
269.814
Qtly Revenue Growth YOY
16.20%
Diluted Eps TTM
50.09
Qtly Earnings Growth YOY
8.70%
Trailing PE
21.74
Forward PE
14
Price Sales TTM
4.0359
Price Book MRQ
4.0286
Enterprise Value Revenue
4
Enterprise Value EBITDA
13
2293.30
0.88%2292.70
0.82%1807.25
0.72%1472.25
0.56%1389.40
0.44%4574.95
0.11%6633.05
-0.27%6638.00
-0.26%1275.40
-0.05%4571.20
-0.02%